Friedman DS, O’Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P and Kempen J; Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 122:564–572. 2004. View Article : Google Scholar : PubMed/NCBI

Klaver CC, Wolfs RC, Vingerling JR, Ofman A and De Jong PT: Age specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol. 116:653–658. 1998. View Article : Google Scholar : PubMed/NCBI

Fine SL, Berger JW, Maguire MG and Ho AC: Age-related macular degeneration. N Engl J Med. 342:483–492. 2000. View Article : Google Scholar : PubMed/NCBI

McConnell V and Silvestri G: Age-related macular degeneration. Ulster Med J. 74:82–92. 2005.PubMed/NCBI

Nowak JZ: Role of lipofuscin in pathogenesis of age-related macular degeneration (AMD). Mag Okul. 2:103–114. 2005.(In Polish).

Nowak JZ: Drusen, basal deposits, inflammation and age-related macular degeneration (AMD). Mag Okul. 2:174–186. 2005.(In Polish).

Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PT, Klaver CC, Klein BE, Klein R, et al: An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 39:367–374. 1995. View Article : Google Scholar : PubMed/NCBI

Anderson DH, Mullins RF, Hageman GS and Johnson LV: A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 134:411–431. 2002. View Article : Google Scholar : PubMed/NCBI

Campochiaro PA: Ocular neovascularization and excessive vascular permeability. Expert Opin Biol Ther. 4:1395–1402. 2004. View Article : Google Scholar : PubMed/NCBI

Kijlstra A, La Heij EC and Hendrikse F: Immunological factors in the pathogenesis and treatment of age-related macular degeneration. Ocular Immunol Inflam. 13:3–11. 2005. View Article : Google Scholar : PubMed/NCBI

Klein R, Peto T, Bird A and Vannewkirk MR: The epidemiology of age-related macular degeneration. Am J Ophthalmol. 137:486–495. 2004. View Article : Google Scholar : PubMed/NCBI

Sparrow JR and Boulton M: RPE lipofuscin and its role in retinal pathobiology. Exp Eye Res. 80:595–606. 2005. View Article : Google Scholar : PubMed/NCBI

Wiktorowska-Owczarek A and Nowak JZ: Oxidative damage in age-related macular degeneration (AMD) and antioxidant protection as a therapeutic strategy. Pol J Environ Stud. 15:69–72. 2006.

Beatty S, Koh H, Phil M, Henson D and Boulton M: The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 45:115–134. 2000. View Article : Google Scholar : PubMed/NCBI

Dunaief JL, Dentchev T, Ying GS and Milam AH: The role of apoptosis in age-related macular degeneration. Arch Ophthalmol. 120:1435–1442. 2002. View Article : Google Scholar : PubMed/NCBI

Winkler BS, Boulton ME, Gottsch JD and Sternberg P: Oxidative damage and age-related macular degeneration. Mol Vis. 5:321999.PubMed/NCBI

Hollyfield JG, Salomon RG and Crabb JW: Proteomic approaches to understanding age-related macular degeneration. Adv Exp Med Biol. 533:83–89. 2003. View Article : Google Scholar : PubMed/NCBI

Jin GF, Hurst JS and Godley BF: Rod outer segments mediate mitochondrial DNA damage and apoptosis in human retinal pigment epithelium. Curr Eye Res. 23:11–19. 2001. View Article : Google Scholar : PubMed/NCBI

Wolf G: Lipofuscin and macular degeneration. Nutr Rev. 61:342–346. 2003. View Article : Google Scholar : PubMed/NCBI

Shamsi FA and Boulton M: Inhibition of the RPE lysosomal and antioxidant activity by the age pigment lipofuscin. Invest Ophthalmol Vis Sci. 42:3041–3046. 2001.PubMed/NCBI

Sundelin S, Wihlmark U, Nilsson SE and Brunk UT: Lipofuscin accumulation in cultured retinal pigment epithelial cells reduces their phagocytic capacity. Curr Eye Res. 17:851–857. 1998. View Article : Google Scholar : PubMed/NCBI

Rakoczy PE, Zhang D, Robertson T, Barnett NL, Papadimitriou J, Constable IJ and Lai CM: Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model. Am J Pathol. 161:1515–1524. 2002. View Article : Google Scholar : PubMed/NCBI

Shaban H, Borras C, Vina J and Richter C: Phosphatidylglycerol potently protects human retinal pigment epithelial cells against apoptosis induced by A2E, a compound suspected to cause age-related macula degeneration. Exp Eye Res. 75:99–108. 2002. View Article : Google Scholar

Suter M, Remé C, Grimm C, Wenzel A, Jaattela M, Esser P, Kociok N, Leist M and Richter C: Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J Biol Chem. 275:39625–39630. 2000. View Article : Google Scholar

Kroemer G and Reed JC: Mitochondrial control of cell death. Nat Med. 6:513–519. 2000. View Article : Google Scholar

Schon EA and Manfredi G: Neuronal degeneration and mitochondrial dysfunction. J Clin Invest. 111:303–312. 2003. View Article : Google Scholar : PubMed/NCBI

James AM and Murphy MP: How mitochondrial damage affects cell function. J Biomed Sci. 9:475–487. 2002. View Article : Google Scholar : PubMed/NCBI

Toescu EC, Myronova N and Verkhratsky A: Age-related structural and functional changes of brain mitochondria. Cell Calcium. 28:329–338. 2000. View Article : Google Scholar : PubMed/NCBI

Paradies G, Ruggiero FM, Petrosillo G and Quagliariello E: Age-dependent decline in the cytochrome c oxidase activity in rat heart mitochondria: role of cardiolipin. FEBS Lett. 406:136–138. 1997.PubMed/NCBI

Crompton M: Mitochondria and aging: a role for the permeability transition. Aging Cell. 3:3–6. 2004. View Article : Google Scholar

Gabbita SP, Subramaniam R, Allouch F, Carney JM and Butterfield DA: Effects of mitochondrial respiratory stimulation on membrane lipids and proteins: an electron paramagnetic resonance investigation. Biochim Biophys Acta. 1372:163–173. 1998. View Article : Google Scholar

Rottenberg H and Wu S: Mitochondrial dysfunction in lymphocytes from old mice: enhanced activation of the permeability transition. Biochem Biophys Res Commun. 240:68–74. 1997. View Article : Google Scholar : PubMed/NCBI

Sugrue MM and Tatton WG: Mitochondrial membrane potential in aging cells. Biol Signals Recept. 10:176–188. 2001. View Article : Google Scholar : PubMed/NCBI

Battelli D, Bellei M, Arrigoni-Martelli E, Muscatello U and Bobyleva V: Interaction of carnitine with mitochondrial cardiolipin. Biochim Biophys Acta. 1117:33–36. 1992. View Article : Google Scholar : PubMed/NCBI

Zammit VA, Corstorphine CG, Kolodziej MP and Fraser F: Lipid molecular order in liver mitochondrial outer membranes, and sensitivity of carnitine palmitoyltransferase I to malonyl-CoA. Lipids. 33:371–376. 1998. View Article : Google Scholar : PubMed/NCBI

Beaumont K, Skowronski R, Vaughn DA and Fanestil DD: Interactions of lipids with peripheral-type benzodiazepine receptors. Biochem Pharmacol. 37:1009–1014. 1988. View Article : Google Scholar : PubMed/NCBI

Campbell AM, Capuano A and Chan SH: A cholesterol-binding and transporting protein from rat liver mitochondria. Biochim Biophys Acta. 1567:123–132. 2002. View Article : Google Scholar : PubMed/NCBI

Hansson M, Ellis E, Hunt MC, Schmitz G and Babiker A: Marked induction of sterol 27-hydroxylase activity and mRNA levels during differentiation of human cultured monocytes into macrophages. Biochim Biophys Acta. 1593:283–289. 2003. View Article : Google Scholar : PubMed/NCBI

Papadopoulos V: Peripheral benzodiazepine receptor: structure and function in health and disease. Ann Pharm Fr. 61:30–50. 2003.PubMed/NCBI

Denton RM, Randle PJ, Bridges BJ, Cooper RH, Kerbey AL, Pask HT, Severson DL, Stansbie D and Whitehouse S: Regulation of mammalian pyruvate dehydrogenase. Mol Cell Biochem. 9:27–53. 1975. View Article : Google Scholar : PubMed/NCBI

Robison WG Jr and Kuwabara T: Microperoxisomes in the retinal pigment epithelium. Invest Ophthalmol. 14:866–872. 1975.PubMed/NCBI

Szabo II, Adams C and Gulbins E: Ion channels and membrane rafts in apoptosis. Pflugers Arch. 448:304–312. 2004. View Article : Google Scholar : PubMed/NCBI

Beuerman RW and Stern ME: Neurogenic inflammation: a first line of defense for the ocular surface. Ocul Surf. 3(Suppl 4): S203–S206. 2005. View Article : Google Scholar : PubMed/NCBI

Troger J, Kieselbach G, Teuchner B, Kralinger M, Nguyen QA, Haas G, Yayan J, Gottinger W and Schmid E: Peptidergic nerves in the eye, their source and potential pathophysiological relevance. Brain Res Rev. 53:39–62. 2007.PubMed/NCBI

Stern ME, Gao J, Siemasko KF, Beuerman RW and Pflugfelder SC: The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res. 78:409–416. 2004. View Article : Google Scholar : PubMed/NCBI

Kovacs I, Ludany A, Koszegi T, Fehér J, Kovacs B, Szolcsanyi J and Pintér E: Substance P released from sensory nerve endings influences tear secretion and goblet cell function in the rat. Neuropeptides. 39:395–402. 2005. View Article : Google Scholar : PubMed/NCBI

Feher J: Contribution of neurogenic inflammation to irritable eye syndrome. Adv Exp Med Biol. 506:1047–1050. 2002. View Article : Google Scholar : PubMed/NCBI

Baudouin C: A new approach for better comprehension of diseases of the ocular surface. J Fr Ophtalmol. 30:239–246. 2007.(In French).

Brecha NC, Sternini C, Anderson K and Krause JE: Expression and cellular localization of substance P/neurokinin A and neurokinin B mRNAs in the rat retina. Vis Neurosci. 3:527–535. 1989. View Article : Google Scholar : PubMed/NCBI

Caruso DM, Owczarzak MT and Pourcho RG: Colocalization of substance P and GABA in retinal ganglion cells: a computer-assisted visualization. Vis Neurosci. 5:389–394. 1990. View Article : Google Scholar : PubMed/NCBI

Bagnoli P, Dal Monte M and Casini G: Expression of neuropeptides and their receptors in the developing retina of mammals. Histol Histopathol. 18:1219–1242. 2003.PubMed/NCBI

May A, Shepheard SL, Knorr M, Effert R, Wessing A, Hargreaves RJ, Goadsby PJ and Diener HC: Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraine. Brain. 121:1231–1237. 1998. View Article : Google Scholar : PubMed/NCBI

Gaspar MN, Ribeiro CA, Cunha-Vaz JG and Macedo TR: Effects of neuropeptides on the sumatriptan-disturbed circulation in the optic nerve head of rabbits. Pharmacology. 70:152–159. 2004. View Article : Google Scholar : PubMed/NCBI

Nucci C, Gasperi V, Tartaglione R, Cerulli A, Terrinoni A, Bari M, De Simone C, Agrò AF, Morrone LA, Corasaniti MT, Bagetta G and Maccarrone M: Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats. Invest Ophthalmol Vis Sci. 48:2997–3004. 2007. View Article : Google Scholar : PubMed/NCBI

Bronzetti E, Artico M, Kovacs I, Felici LM, Magliulo G, Vignone D, D’Ambrosio A, Forte F, Di Liddo R and Feher J: Expression of neurotransmitters and neurotrophins in neurogenic inflammation of the rat retina. Eur J Histochem. 51:251–260. 2007.PubMed/NCBI

Szolcsanyi J: Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptide. 38:377–384. 2004.PubMed/NCBI

Fujita S, Shimizu T, Izumi K, Fukuda T, Sameshima M and Ohba N: Capsaicin-induced neuroparalytic keratitis-like corneal changes in the mouse. Exp Eye Res. 38:165–175. 1984. View Article : Google Scholar : PubMed/NCBI

Ogilvy CS, Silverberg KR and Borges LF: Sprouting of corneal sensory fibers in rats treated at birth with capsaicin. Invest Ophthalmol Vis Sci. 32:112–121. 1991.PubMed/NCBI

Gallar J, Pozo MA, Rebollo I and Belmonte C: Effects of capsaicin on corneal wound healing. Invest Ophthalmol Vis Sci. 31:1968–1974. 1990.PubMed/NCBI

Waldrep JC and Crosson CE: Induction of keratouveitis by capsaicin. Curr Eye Res. 7:1173–1182. 1988. View Article : Google Scholar : PubMed/NCBI

Ritter S and Dinh TT: Capsaicin-induced neuronal degeneration in the brain and retina of preweanling rats. J Comp Neurol. 296:447–461. 1990. View Article : Google Scholar : PubMed/NCBI

Tombran-Tink J, Shivaram SM, Chader GJ, Johnson LV and Bok D: Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity. J Neurosci. 15:4992–5003. 1995.PubMed/NCBI

Becerra SP, Palmer I, Kumar A, Steele F, Shiloach J, Notario V and Chader GJ: Overexpression of fetal human pigment epithelium-derived factor in Escherichia coli: a functionally active neurotrophic factor. J Biol Chem. 268:23148–23156. 1993.PubMed/NCBI

Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W and Bouck NP: Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 285:245–258. 1999. View Article : Google Scholar : PubMed/NCBI

Chung C, Doll JA, Stellmach VM, Gonzales J, Surapureddi S, Cornwell M, Reddy JK and Crawford SE: Pigment epithelium-derived factor is an angiogenesis and lipid regulator that activates peroxisome proliferator-activated receptor alpha. Adv Exp Med Biol. 617:591–597. 2008. View Article : Google Scholar

Bouck N: PEDF: anti-angiogenic guardian of ocular function. Trends Mol Med. 8:330–334. 2002. View Article : Google Scholar : PubMed/NCBI

Spranger J, Osterhoff M, Reimann M, Mohlig M, Ristow M, Francis MK, Cristofalo V, Hammes HP, Shith G, Boulton M and Pfeiffer AF: Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes. 50:2641–2645. 2001. View Article : Google Scholar : PubMed/NCBI

Zingsheim HP and Plattner H: Electron microscopic methods in membrane biology. Methods in Membrane Biology. Korn ED: Plenum Press; New York, NY: 1. –146. 1976, View Article : Google Scholar

Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G and Smith MA: Mitochondrial abnormalities in Alzheimer’s disease. J Neurosci. 21:3017–3023. 2001.

Kelley DE, He J, Menshikova EV and Ritov VB: Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 51:2944–2950. 2002. View Article : Google Scholar : PubMed/NCBI

Gosker HR, Wouters EFM, van der Vusse GJ and Schols AMWJ: Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr. 71:1033–1047. 2000.PubMed/NCBI

Ben-Shachar D: Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J Neurochem. 83:1241–1251. 2002. View Article : Google Scholar : PubMed/NCBI

Fox DA, Poblenz AT, He L, Harris JB and Medrano CJ: Pharmacological strategies to block rod photoreceptor apoptosis caused by calcium overload: a mechanistic target-site approach to neuroprotection. Eur J Ophthalmol. 13(Suppl 3): S44–S56. 2003.PubMed/NCBI

Tyni T, Johnson M, Eaton S, Pourfarzam M, Andrews R and Turnbull DM: Mitochondrial fatty acid beta-oxidation in the retinal pigment epithelium. Pediatr Res. 52:595–600. 2002.PubMed/NCBI

Andrews RM, Griffiths PG, Johnson MA and Turnbull DM: Histochemical localisation of mitochondrial enzyme activity in human optic nerve and retina. Br J Ophthalmol. 83:231–235. 1999. View Article : Google Scholar : PubMed/NCBI

Hiltunen JK and Qin Y: Beta-oxidation-strategies for the metabolism of a wide variety of acyl-CoA esters. Biochem Biophys Acta. 1484:117–128. 2000.PubMed/NCBI

Kuksa V, Imanishi Y, Batten M, Palczewski K and Moise AR: Retinoid cycle in the vertebrate retina: experimental approaches and mechanisms of isomerization. Vision Res. 43:2959–2981. 2003. View Article : Google Scholar : PubMed/NCBI

Sparrow JR, Fishkin N, Zhou J, Cai B, Jang YP, Krane S, Itagaki Y and Nakanishi K: A2E, a byproduct of the visual cycle. Vision Res. 43:2983–2990. 2003. View Article : Google Scholar : PubMed/NCBI

Sprecher H: Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta. 1486:219–231. 2000. View Article : Google Scholar : PubMed/NCBI

Hettema EH and Tabak HF: Transport of fatty acids and metabolites across the peroxisomal membrane. Biochim Biophys Acta. 1486:18–27. 2000. View Article : Google Scholar : PubMed/NCBI

Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Wilson TM, Lenhard JM and Lehmann JM: Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA. 94:4318–4323. 1997. View Article : Google Scholar

Kersten S, Desvergne B and Wahli W: Roles of PPARs in health and disease. Nature. 405:421–424. 2000. View Article : Google Scholar : PubMed/NCBI

Nagy L, Tontonoz P, Alvarez JGA, Chen H and Evans RM: Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell. 93:229–240. 1998. View Article : Google Scholar : PubMed/NCBI

Murata T, He S, Hangai M, Ishibashi T, Xi XP, Kim S, Hsueh WA, Ryan SJ, Law RE and Hinton DR: Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization. Invest Ophthalmol Vis Sci. 41:2309–2317. 2000.PubMed/NCBI

Forman BM, Chen J and Evans RM: Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA. 94:4312–4317. 1997. View Article : Google Scholar

Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K and Wahli W: Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci USA. 90:2160–2164. 1993. View Article : Google Scholar

Brunk UT and Terman A: The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem. 269:1996–2002. 2002. View Article : Google Scholar : PubMed/NCBI

Katz ML, Rice LM and Gao CL: Reversible accumulation of lipofuscin-like inclusions in the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 40:175–181. 1999.PubMed/NCBI

Von Ruckmann A, Schmidt KG, Fitzke FW, Bird AC and Jacobi KW: Dynamics of accumulation and degradation of lipofuscin in retinal pigment epithelium in senile macular degeneration. Klin Monbl Augenheilkd. 213:32–37. 1998.(In German).

Kennedy CJ, Rakoczy PE and Constable IJ: Lipofuscin of the retinal pigment epithelium: a review. Eye (Lond). 9:763–771. 1995. View Article : Google Scholar : PubMed/NCBI

Marmorstein AD, Marmorstein LY, Sakaguchi H and Hollyfield JG: Spectral profiling of autofluorescence associated with lipofuscin, Bruch’s membrane, and sub-RPE deposits in normal and AMD eyes. Invest Ophthalmol Vis Sci. 43:2435–2441. 2002.PubMed/NCBI

Feher J, Kovacs I, Artico M, Cavallotti C, Papale A and Balacco Gabrieli C: Mitochondrial aterations of retinal pigment epithelium in age-related macular degeneration. Neurobiol Aging. 27:983–993. 2006. View Article : Google Scholar : PubMed/NCBI

Furuno T, Kanno T, Arita K, Asami M, Utsumi T, Doi Y, Inoue M and Utsumi K: Roles of long chain fatty acids and carnitine in mitochondrial membrane permeability transition. Biochem Pharmacol. 62:1037–1046. 2001. View Article : Google Scholar : PubMed/NCBI

Pepe S: Mitochondrial function in ischaemia and reperfusion of the ageing heart. Clin Exp Pharmacol Physiol. 27:745–750. 2000. View Article : Google Scholar : PubMed/NCBI

Gunthorpe MJ and Szallasi A: Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms. Curr Pharm Des. 14:32–41. 2008. View Article : Google Scholar : PubMed/NCBI

Lázár J, Szabó T, Marincsák R, Kovács L, Blumberg PM and Bíró T: Sensitization of recombinant vanilloid receptor-1 by various neurotrophic factors. Life Sci. 75:153–163. 2004.PubMed/NCBI

Aloe L, Tirassa P and Lambiase A: The topical application of nerve growth factor as a pharmacological tool for human corneal and skin ulcers. Pharmacol Res. 57:253–258. 2008. View Article : Google Scholar : PubMed/NCBI

Feher J, Kovacs I, Pacella E, Keresz S, Spagnardi N and Balacco Gabrieli C: Pigment epithelium-derived factor (PEDF) attenuated capsaicin-induced neurotrophic keratouveitis. Invest Ophthalmol Vis Sci. 50:5173–5180. 2009. View Article : Google Scholar : PubMed/NCBI

Gao G, Li Y, Zhang D, Gee S, Crosson C and Ma J: Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett. 489:270–276. 2001. View Article : Google Scholar : PubMed/NCBI

Jin KL, Mao XO and Greenberg DA: Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci USA. 97:10242–10247. 2000. View Article : Google Scholar : PubMed/NCBI

Zachary I: Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neurosignals. 14:207–221. 2005. View Article : Google Scholar

Khaibullina AA, Rosenstein JM and Krum JM: Vascular endothelial growth factor promotes neurite maturation in primary CNS neuronal cultures. Brain Res Dev Brain Res. 148:59–68. 2004. View Article : Google Scholar : PubMed/NCBI

Feher J, Papale A, Mannino G, Gualdi G and Balacco Gabrieli C: Mitotropic compounds for the treatment of age-related macular degeneration. The metabolic approach and a pilot study. Ophthalmologica. 217:351–357. 2003. View Article : Google Scholar : PubMed/NCBI